**Counterfeit Cancer Medications Alerted Nationwide by NAFDAC** The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a nationwide alert over the circulation of counterfeit cancer medications, specifically Avastin and Tecentriq. The agency warned that the fake products pose serious health risks to patients. In a public notice, NAFDAC confirmed the discovery of falsified batches of Avastin 400mg/16ml (Bevacizumab) and Tecentriq (Atezolizumab) in the country. According to NAFDAC, the counterfeit Avastin and Tecentriq were discovered in various locations across the nation. The agency stated that the fake products were found to be packaged in counterfeit packaging, which closely resembles the genuine packaging of the medications. NAFDAC Director-General, **Prof. Mojisola Adeyeye**, emphasized the dangers of consuming counterfeit cancer medications, stating that "the fake products can cause serious harm to patients, including death." The alert was issued following a thorough investigation by NAFDAC, which revealed that the counterfeit medications were being sold to unsuspecting patients. The agency warned that patients who have purchased the fake products should seek immediate medical attention and report the incident to the nearest NAFDAC office. NAFDAC also advised healthcare providers to be vigilant and verify the authenticity of cancer medications before administering them to patients. In a statement, NAFDAC urged patients and healthcare providers to report any suspicious cancer medications to the agency. The agency also encouraged patients to purchase medications from authorized distributors and to verify the authenticity of medications by checking the batch numbers and expiration dates. NAFDAC assured the public that it is working tirelessly to prevent the circulation of counterfeit cancer medications nationwide. NAFDAC's public notice advised patients to be cautious when purchasing cancer medications, stating that "the fake products can cause serious harm to patients, including death." The agency urged patients to seek medical attention immediately if they have consumed the fake products.